Hypoxic cancer cells are resistant to treatment, leading to the selection of cells with a more malignant phenotype. The expression of interleukin-8 (IL-8) plays an important role in the tumorigenesis and metastasis of solid tumors including prostate cancer. Recently, we detected elevated expression of IL-8 and IL-8 receptors in human prostate cancer tissue. The objective of the current study was to determine whether hypoxia increases IL-8 and IL-8 receptor expression in prostate cancer cells and whether this contributes to a survival advantage in hypoxic cells. IL-8, CXCR1 and CXCR2 messenger RNA (mRNA) expression in PC3 cells was upregulated in response to hypoxia in a time-dependent manner. Elevated IL-8 secretion following hypoxia was detected by enzymelinked immunosorbent assay, while immunoblotting confirmed elevated receptor expression. Attenuation of hypoxia-inducible factor (HIF-1) and nuclear factor-jB (NF-jB) transcriptional activity using small interfering RNA (siRNA), a HIF-1 dominant-negative and pharmacological inhibitors, abrogated hypoxia-induced transcription of CXCR1 and CXCR2 in PC3 cells. Furthermore, chromatin-IP analysis demonstrated binding of HIF-1 and NF-jB to CXCR1. Finally, inhibition of IL-8 signaling potentiated etoposide-induced cell death in hypoxic PC3 cells. These results suggest that IL-8 signaling confers a survival advantage to hypoxic prostate cancer cells, and therefore, strategies to inhibit IL-8 signaling may sensitize hypoxic tumor cells to conventional treatments.
Introduction
Prostate cancer is the most frequently diagnosed male cancer and the second leading cause of cancer-related deaths in men in Western society. There are currently few suitable biomarkers for early diagnosis of prostate cancer and, consequently, patients frequently present with advanced disease. Solid human tumors contain regions deficient in oxygen (hypoxia), constituting an important cause of resistance to treatment. Hypoxia has been detected (Movsas et al., 1999; Carnell et al., 2006) and is an adverse clinical prognostic factor for prostate cancer. Hypoxic prostate cancer cells frequently demonstrate an increased rate of proliferation and angiogenesis and decreased sensitivity to chemotherapy or radiotherapy (Cvetkovic et al., 2001; Ghafar et al., 2003) . The hypoxic microenvironment may therefore select for aggressive, therapy-resistant tumor cells (Cairns et al., 2003; Subarsky and Hill, 2003; Cairns and Hill, 2004) .
The pathophysiological response of tumors to hypoxia, including angiogenesis and metastasis, arise from changes in gene expression. The activity of several transcription factors, including hypoxia-inducible factor (HIF-1) (Semenza and Wang, 1992) , p53 (Graeber et al., 1994) , AP-1 (Yao et al., 1994) , C/EBPb (Yan et al., 1997) , early growth response 1 (Egr-1) (Yan et al., 1999) and nuclear factor-kB (NF-kB) (Koong et al., 1994) are upregulated in hypoxic cells and, subsequently, a large number of hypoxia-inducible genes have been described. Changes in gene expression may increase tumor oxygenation, while others may allow the tumor cells to adapt to decreased oxygen levels through regulation of metabolic and death signal pathways.
The expression of pro-angiogenic cytokines are known to underpin the tumorigenesis, proliferation and metastasis of many cancer types. In vitro exposure of several different tumor cell types to hypoxia leads to elevated levels of both interleukin-8 (IL-8) mRNA and protein (Shi et al., 1999; Xu et al., 1999) , while in vivo analysis by immunohistochemistry and in situ hybridization of tumor sections has localized IL-8 expression adjacent to necrotic zones, suggesting that IL-8 expression is regulated by hypoxia within the tumor microenvironment (Kunz et al., 1999; Xu et al., 1999) . IL-8 regulates angiogenesis by enhancing the proliferation, survival and migration of endothelial cells (Li et al., 2003 . Consequently, IL-8 expression has been correlated with an aggressive phenotype in bladder and prostate cancer (Inoue et al., 2000a, b) .
The regulation of chemokine signaling under hypoxia is also controlled at the level of receptor expression. Expression of CXCR4 is induced on many cell types in response to hypoxia, thus potentiating the chemotactic response of cells to stromal-derived factor, (Schioppa et al., 2003) . Recently, we detected elevated expression of IL-8 and each of the IL-8 receptors, CXCR1 and CXCR2 in human prostate cancer tissue (Murphy et al., 2005) . Therefore, the current study was undertaken to determine whether hypoxia can represent an environmental stress that may underpin the upregulation of not only IL-8 but also the IL-8 receptors in prostate cancer cells.
Results

Hypoxia induces expression of IL-8 and the IL-8 receptors
The effect of hypoxia on the expression of IL-8 and the IL-8 receptors, CXCR1 and CXCR2, was examined in the PC3 prostate cancer cell line. Real-time PCR analysis indicated a rapid, time-dependent increase in IL-8 mRNA levels in PC3 cells upon culture in hypoxia ( Figure 1a ). IL-8 mRNA expression was induced by threefold as early as 1 h following exposure to hypoxia, with a maximal induction of fivefold over normoxic levels observed at 6 h ( Figure 1a ). The hypoxia-induced upregulation of IL-8 mRNA was reversible and expression rapidly returned to basal levels when PC3 cells were returned to a normoxic environment (Figure 1b) .
The expression and secretion of IL-8 by PC3 cells was also examined. Immunoblotting demonstrated increased IL-8 protein expression in response to hypoxia, with maximal expression observed 6 h postinduction of hypoxia ( Figure 1c ). IL-8 secretion by PC3 cells also increased in a time-dependent manner upon exposure to hypoxia (Figure 1d ). Relative to a time-matched control, we observed a maximal fourfold increase in IL-8 secretion over normoxic levels 8 h after exposure to hypoxia (Figure 1d ). IL-8 expression in the cell culture media of hypoxic PC3 cells was shown to return to near normoxic levels after 16 h in hypoxia but became elevated again following 24 h in hypoxia.
We examined the expression of the IL-8 receptors, CXCR1 and CXCR2, under hypoxic conditions (Figure 2) . The levels of CXCR1 (Figure 2a , left panel) and CXCR2 ( Figure 2a , right panel) mRNA transcripts were dramatically upregulated in response to hypoxia in a time-dependent manner. CXCR1 mRNA expression initially peaked when PC3 cells were exposed to hypoxia for 2 h followed by a more dramatic induction, with maximal upregulation of CXCR1 mRNA occurring after 16 h in hypoxia (Figure 2a , left panel). CXCR2 mRNA transcript levels initially peaked in PC3 cells following exposure to hypoxia for 2 h, with transcript levels reaching a maximal level of induction during a second increase, detected between 6 and 16 h culture in hypoxia ( Figure 2a Flow cytometry and IP-western immunoblotting were used to detect altered expression of CXCR1 and CXCR2 receptors. Total CXCR1 and CXCR2 protein levels in PC3 cells were maximal following culture in hypoxia for 24 or 48 h (Figure 2c ). Cell surface CXCR1 and CXCR2 expression, as measured by flow cytometry, was also increased upon exposure in hypoxia (Figure 2d ).
Hypoxia induces HIF-1 and NF-kB and their target genes in PC3 cells Many cellular responses to hypoxia are mediated by the hypoxia-inducible transcription factor HIF-1. Real-time PCR analysis indicated no change in HIF-1a mRNA transcript levels in PC3 cells over a 24 h time-course (Figure 3a) . In contrast, immunoblotting demonstrated a rapid increase in HIF-1a protein in nuclear extracts ( Figure 3b ). HIF-1a protein levels were elevated following exposure of PC3 cells to hypoxia for 1 h and this was maintained for 24 h. HIF-1b expression remained constant upon exposure to hypoxia (Figure 3b ).
To confirm HIF-1 transcriptional activity in hypoxic PC3 cells, we used real-time PCR to analyse the transcript levels of the known HIF-1 target gene carbonic anhydrase IX (CA IX). We observed time-dependent increases in CA IX mRNA transcript levels in response to hypoxia. To demonstrate the relationship to HIF-1a, we employed a published siRNA strategy to deplete HIF-1 expression ( Figure 3d , left panel) and re-examined the effect on this HIF-1 target gene. The hypoxia-induced expression of CA IX (Figure 3d , right panel) was inhibited by 97% in the presence of the siRNA oligonucleotide directed against HIF-1a relative to mock transfected cells, thus confirming that HIF-1 is active and regulates CA IX expression in hypoxic PC3 cells. In contrast, a scrambled oligonucleotide had no effect on either HIF-1a or CA IX expression ( Figure 3d ).
Activation of the transcription factor NF-kB is also induced in response to hypoxia (Lee and Avraham, 2002) . Using electrophoretic mobility shift assays (EMSA), we detected time-dependent and increased NF-kB-binding activity to an oligonucleotide containing the nucleotide consensus sequence for NF-kB after exposure of PC3 cells to hypoxia (Figure 4a ). The expression of the NF-kB target gene Bcl-2 was also examined by real-rime PCR (Figure 4b ). Bcl-2 mRNA transcript levels increased in a time-dependent manner in hypoxic cells, with maximal induction observed 6 h after exposure to hypoxia. This response was attenuated in the presence of a siRNA oligonucleotide targeted against the Rel A subunit of NF-kB ( Figure 4c ), with Bcl-2 mRNA levels decreasing to 17% of that detected in mock-transfected hypoxic cells ( Figure 4d , left panel). NF-kB is also reported to regulate IL-8 expression (Yasumoto et al., 1992) . Hypoxia-induced upregulation of IL-8 in PC3 cells ( Figure 1a HIF-1 and NF-kB regulate expression of CXCR1 and CXCR2 in response to hypoxia We next investigated the role of HIF-1 and NF-kB in underpinning the hypoxia-induced regulation of CXCR1 and CXCR2. HIF-1a or NF-kB expression and/or activity was attenuated using either molecular or pharmacological strategies. PC3 cells were pretreated with siRNA oligonucleotide sequences directed against either HIF-1 or NF-kB for 24 h, before exposure to hypoxia for 2 and 8 h. The impact of suppressing each transcription factor upon the transcription of each receptor was then determined using real-time PCR analysis of CXCR1 and CXCR2 mRNA transcripts. CXCR1 mRNA transcript levels were almost completely abrogated in the presence of HIF-1a siRNA compared to mock-transfected cells upon exposure to hypoxia for 2 or 8 h (Figure 5a, left panel) . Furthermore, CXCR1 mRNA expression was reduced to 22% of control levels following exposure to hypoxia for 2 h and 42% following 8 h exposure to hypoxia in the presence of a HIF-1 dominant-negative construct (Figure 5a , right panel). The expression of CXCR2 was also downregulated, by approximately 90%, when PC3 cells were exposed to hypoxia for 2 or 8 h in cells transfected with HIF-1a siRNA (Figure 5b , left panel). Moreover, CXCR2 mRNA transcript levels were reduced to 56 and 31% of control levels following exposure to hypoxia for 2 and 8 h, respectively, in the presence of the HIF-1 dominant-negative construct (Figure 5b, right panel) .
Suppression of Rel A/NFkB using siRNA also blocked hypoxia-induced upregulation of CXCR1 by 90% when cells were exposed to hypoxia for 2 h (Figure 5a , left panel) and abrogated the response at the 8 h time-point (Figure 5a , left panel). The Rel A siRNA strategy also inhibited the hypoxia-induced upregulation of CXCR2 by 69 and 90% at the 2 and 8 h time-points, respectively (Figure 5b, left panel) . Similar responses in attenuating CXCR1 and CXCR2 transcription were obtained following pretreatment of the hypoxic PC3 cells with the NF-kB inhibitor BAY11-7082. CXCR1 transcript levels were reduced to 25% of control levels following exposure to hypoxia for 2 h and 17% following 8 h in the presence of BAY11-7082 ( Figure 5a , right panel). Addition of BAY11-7082 also downregulated CXCR2 mRNA expression to 44% of control levels following exposure to hypoxia for 2 h and 58% following 8 h (Figure 5b , right panel) compared to control hypoxic cells. The combined inhibition of HIF-1 and NF-kB using a siRNA approach did not reveal any additional downregulation of either CXCR1 or CXCR2 expression under hypoxic conditions (Figure 5c ). Chromatin-IP analysis was carried out to demonstrate that HIF-1 and NF-kB could bind directly to CXCR1. As shown, both HIF-1 (Figure 5d , left panel) and NF-kB (Figure 5d , right panel) could be detected on the promoter region of CXCR1. Taken together, these results suggest that NF-kB and HIF-1 may play a role in the regulation of the IL-8 receptors in response to hypoxia.
IL-8 signaling contributes to a survival advantage in PC-3 cells in hypoxia
To determine the functional importance of potentiating autocrine/paracrine IL-8 signaling in hypoxic prostate cancer cells, we adopted a siRNA approach to suppress selectively either the ligand or concurrently abrogate (Figure 6a) . Similarly, the IL-8 mRNA transcript level was attenuated by 66% using the commercial siRNA oligonucleotide pool (Figure 6b ). PC-3 cells are inherently resistant to hypoxia-induced apoptosis (Fernandez et al., 2001 ). Inhibition of IL-8 signaling using siRNA had no effect on the basal growth or viability of PC3 cells under hypoxia (data not shown). However, further experiments were conducted to observe the effect of inhibiting hypoxia-induced IL-8 signaling upon the viability of hypoxic PC3 cells when challenged with a chemotherapeutic agent. The response of hypoxic and normoxic PC3 cells following exposure to etoposide (10 mM) for 48 h was examined. Cells cultured under normoxia displayed greater sensitivity to etoposide than those cells cultured in hypoxia. Under normoxia, treatment with etoposide (10 mM) caused a 20% reduction in cell viability compared to untreated cells (Figure 6c ). In contrast, we observed only an 8.5% reduction in viability in response to etoposide in hypoxic PC3 cells. Inhibition of IL-8 signaling using siRNA increased the sensitivity of hypoxic PC3 cells to etoposide (10 mM), reducing cell viability to 23% of that of untreated cells (Po0.05; Figure 6c ). In addition, co-transfection with both siRNA-oligonucleotide pools directed against the two receptors CXCR1 and CXCR2 reduced cell viability in response to etoposide by 20% (Figure 6c ), compared to the 8.5% decrease in hypoxic cells exposed to etoposide alone (Po0.05).
To associate further hypoxia-induced IL-8 signaling in regulating cell survival, we conducted additional realtime PCR to determine whether the suppression of IL-8 signaling under hypoxic conditions coincided with a decrease in the expression of the anti-apoptotic, NF-kBregulated gene Bcl-2. Etoposide (10 mM) was administered to hypoxic PC3 cells, transfected with either a cocktail of CXCR1-and CXCR2-targeting siRNA oligonucleotides or a scrambled siRNA oligonucleotide at an equivalent final concentration. The analysis confirmed that the suppression of hypoxia-induced CXCR1 and CXCR2 expression and the resultant loss of hypoxia-induced autocrine/paracrine IL-8 signaling in PC3 cells was accompanied by an 85% downregulation of Bcl-2 transcript levels relative to that detected in scrambled oligonucleotide transfected hypoxic cells (Figure 6d ).
Discussion
Exposure to hypoxia is inevitable in the development of a solid tumor (Vaupel, 2004; Hirota and Semenza, 2006) . Cancer cells respond to hypoxia by regulating the transcription and increasing the expression of angiogenic factors that act upon endothelial cells to promote new blood vessel formation and upon hypoxic cancer cells to induce cell survival. This process is proposed to select for either those cancer cells within the tumor that have adapted to hypoxia through upregulation of prosurvival, proangiogenic or prometastatic genes or alternatively, by selecting those cells which harbor a genetic basis that promotes cell survival signaling for example PTEN mutations or deletions. In addition, hypoxic cancer cells are considered to be resistant to therapy, since many therapeutic strategies are dependent upon an oxidative environment for their function. The elevated activation of cell survival signals in hypoxic cells may also functionally antagonize chemotherapy and radiotherapy-induced cytotoxicity.
The induction of IL-8 mRNA and protein in response to hypoxia has been reported in numerous different tumor types (Desbaillets et al., 1997; Xu et al., 1999 Xu et al., , 2004 Shi et al., 2001) . AP-1 and NF-kB transcription factors promote IL-8 gene transcription in pancreatic cancer cells (Shi et al., 2001) , while HIF-1 has been reported to regulate IL-8 transcription in hypoxic endothelial cells (Kim et al., 2006) . In this current study, we have demonstrated a rapid upregulation of IL-8 transcript levels and IL-8 protein secretion in the PC3 prostate cancer cell line in response to the onset of hypoxia. However, the transcription of the gene was transient and was decreased following restoration of normal oxygen tension. Our data also suggest that NFkB rather than HIF-1 activity regulates IL-8 gene transcription in hypoxic PC3 cells.
While previous studies have shown the regulation of CXCR1 and CXCR2 in vascular endothelial cells and cardiomyocytes in response to hypoxia and reoxygenation (Grutkoski et al., 1999; Moldobaeva and Wagner, 2005) , to our knowledge, the regulation of CXCR1 and CXCR2 expression in epithelial-derived cancer cells has not previously been examined. Our present data illustrate a rapid and reversible upregulation of both CXCR1 and CXCR2 mRNA transcript levels and protein expression in PC3 cells in response to hypoxia. Thus, the concurrent induction of both IL-8 and its receptors may give rise to increased autocrine/paracrine IL-8 signaling in hypoxic PC3 cells. Despite observing marked increases in total receptor expression by immunoblotting, flow cytometry analysis only revealed a modest increase in cell surface expression of either receptor 24 h postinduction of hypoxia. Enzyme-linked immunosorbent assay (ELISA) analysis also indicated a relative decrease in extracellular IL-8 levels at these time-points. Therefore, we suggest that these observations are consistent with an increased level of autocrine/paracrine signaling in hypoxic PC3 cells; that is, the increased receptor pool is able to bind and sequester an increased amount of agonist, resulting in an acceleration of agonist-induced receptor internalization. Internalization of the IL-8 receptor pool has been inferred from our previous studies of PC3 cells under normoxia where immunocytochemistry revealed the majority of the IL-8 receptor pool was colocalized in the cytoplasm with the endosomal marker, transferrin (Murphy et al., 2005) .
While AP-1 and NF-kB regulate IL-8 transcription (Shi et al., 2001) , the mechanism regulating the transcription of the CXCR1 and CXCR2 genes is poorly characterized. Expression of the CXCR4 receptor is induced by the hypoxia-promoted HIF-1 (Schioppa et al., 2003; Staller et al., 2003) and NF-kB (Lee and Avraham, 2002) activity. We observed that pharmacological and molecular inhibition of either NF-kB or HIF-1 resulted in decreased transcription of the CXCR1 and CXCR2 genes under hypoxia. To confirm that these transcription factors bind to the promoter region of these chemokine receptors, we conducted chromatin-IP experiments, using antibodies targeted to HIF-1 or NFkB to precipitate cross-linked DNA/protein fragments and a RT-PCR protocol to amplify the CXCR1 promoter sequence in these precipitated DNA fragments. Consequently, we confirmed that HIF-1 and NFkB could be detected on the promoter region of the CXCR1 receptor. Computational analysis (TRANS-FAC database) (Wingender et al., 2000) of transcription factor binding sites within the CXCR1 promoter sequence also predicted putative binding sites for both HIF-1 and NF-kB on the CXCR1 promoter, identifying five potential binding sites for NF-kB and one potential site for interaction with HIF-1. Although chromatin-IP analysis of the CXCR2 promoter was not conducted, computational analysis of the CXCR2 promoter predicts three potential binding sites for HIF-1 and seven for NF-kB. Further in-depth analysis, including the use of deletion and mutational constructs of the CXCR1 and CXCR2 promoters will be necessary to confirm and map the binding sites of these transcription factors on these genes. In addition, further ChIP-on-ChIP analysis will determine whether the NF-kB and HIF-1 transcription factors bind concurrently or interact with each other on these promoters. Acute hypoxia has been shown to induce the activity of prosurvival pathways in hypoxic prostate cancer cells, providing an explanation for their inherent resistance to either hypoxia-induced or therapy-induced apoptosis (Fernandez et al., 2001; Ghafar et al., 2003; Coffey et al., 2005) . Although the inhibition of IL-8 signaling had no observed effect on the basal growth of PC3 cells under hypoxic conditions, etoposide-induced cell death was enhanced in hypoxic PC3 cells when IL-8 signaling was disrupted by repression of either IL-8 or IL-8 receptor expression. Indeed the inhibition of IL-8 signaling rendered hypoxic cells equally sensitive to the effects of etoposide as cells cultured in normoxia. Furthermore, we have demonstrated that the attenuation of hypoxiainduced IL-8 signaling in PC3 cells leads to a concurrent downregulation of Bcl-2 transcript expression under these conditions. This suggests that NF-kB transcriptional activity is decreased upon downregulation of IL-8 signaling in hypoxic cells and provides a mechanism that may explain the increased sensitivity of hypoxic prostate cancer cells to etoposide when IL-8 signaling is impaired. Other studies from our laboratory have confirmed that IL-8 signaling potentiates NF-kB-mediated transcription of antiapoptotic genes (Wilson et al., in preparation) and activates the phosphoinositide-3 kinase (PI3K)/Akt and mitogenactivated protein kinase (MAPK) signaling cascades in PC3 cells (MacManus et al., 2007) , pathways that are central to cell survival (Takami et al., 2002; Heidemann et al., 2003) and whose activity is increased in hypoxic cells (Trisciuoglio et al., 2005) . Therefore, we suggest that IL-8 signaling may enable the survival of hypoxic prostate cancer cells and that strategies to inhibit IL-8 signaling may be a therapeutic option to sensitize hypoxic prostate cancer cells to conventional chemotherapy.
The importance of IL-8 in regulating angiogenesis in xenograft models of cancer, including prostate cancer is well documented (Smith et al., 1994; Yoneda et al., 1998; Moore et al., 1999; Mizukami et al., 2005) . Our current observations provide further insight into the potential importance of hypoxia-induced IL-8 signaling in promoting tumor growth and progression. The increased expression of CXCR1 and CXCR2 in hypoxic cancer cells potentiates autocrine/paracrine IL-8 signaling, the result of which appears to enhance cell survival, exemplified by our observations that inhibition of IL-8 signaling sensitizes these cells to etoposide. Thus, hypoxia-induced IL-8 signaling will promote tumor growth through coordination of cancer cell survival and through the promotion of angiogenesis. Accordingly, inhibiting IL-8 signaling may have therapeutic benefit in enhancing tumor regression by sensitizing hypoxic, chemoresistant cancer cells to therapy, while concurrently attenuating neovascularization within the hypoxic tumor microenvironment. Furthermore, in demonstrating that hypoxia increases the transcription of IL-8, CXCR1 and CXCR2, our results suggest that hypoxia may be an environmental stimulus that underpins the increased expression of this chemokine and its receptors previously detected in prostate cancer tissue (Murphy et al., 2005) .
Materials and methods
Cell culture and reagents PC3 cells were maintained in RPMI-1640 supplemented with 10% fetal calf serum, 1 mM sodium pyruvate and 2 mM L-glutamine (Invitrogen Life Technologies, Paisley, Scotland) Brown et al., 2005) for 24 h before exposure to hypoxia for 2 or 8 h. For siRNA treatments, previously published oligonucleotides corresponding to nucleotide sequences of HIF-1a (75 nM, Sowter et al., 2003) or Rel A (200 nM, Takaesu et al., 2003) were synthesized commercially (Dharmacon Inc., Chicago, IL, USA) and used at the concentrations previously described. Commercially synthesized oligonucleotide pools (Dharmacon Inc.) were used to target specifically IL-8 (10 nM), CXCR1 (1 nM) and CXCR2 (1 nM). A scrambled oligonucleotide (Sowter et al., 2003) was included in all experiments at the same concentration as the siRNA sequence used. In experiments where more than one siRNA sequence was used, the scrambled sequence was included at a concentration corresponding to the highest concentration of siRNA present. For the complete inhibition of IL-8 signaling, siRNA oligonucleotide pools targeting CXCR1 and CXCR2 were used in combination, at a final concentration of 1 nM CXCR1 siRNA and 1 nM CXCR2 siRNA. PC3 cells (40% confluency) were washed twice in sterile PBS, then incubated with supplemented RPMI-1640 media, genejuice (Invitrogen Life Technologies) and the specific oligonucleotides for 24 h (HIF-1a and Rel A) or 72 h (CXCR1, CXCR2 and IL-8). Depletion of HIF-1a, Rel A, IL-8, CXCR1 or CXCR2 expression in transfected cells was confirmed by real-time quantitative PCR and immunoblotting.
NF-kB inhibitor treatments PC3 cells (1 Â 10 5 ) were washed twice with sterile PBS then replenished with supplemented RPMI-1640 media incorporating BAY11-7082 (5 mM, Calbiochem, San Diego, CA, USA) for 24 h before exposure to hypoxia for 2 or 8 h. Control cells were exposed to an equivalent concentration of dimethyl sulfoxide (DMSO).
Cell viability assays
Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Mosmann, 1983) in 96-well plates. Cells (1 Â 10 3 /well) were transfected with siRNA as described above, replenished with fresh medium 24 h post-transfection with or without etoposide (10 mM). Cells were exposed to normoxia or hypoxia for 48 h, after which 50 ml MTT (0.5 mg/ml) was added to each well and cells were incubated at 371C in normoxia for 3 h. Formazan crystals were reabsorbed in 200 ml DMSO and cell viability determined by reading absorbance at 570 nm using a microplate reader (Molecular Devices, Wokingham, UK).
Total protein extraction
Cells were washed in PBS, harvested and resuspended in ELB (0.25 M NaCl, 0.1% IGEPAL, 50 mM HEPES, 5 mM ethylenediaminetetraacetic acid (EDTA), 500 mM dithiothreitol (DTT)) containing 1 protease inhibitor tablet (Roche, Hertfordshire, UK) per 10 ml ELB. Cells were lysed by passing though a needle (21 gauge) and centrifuged at 10 000 g for 15 min. Protein concentrations were determined using the BCA Protein Assay Reagent (Pierce, Rockford, IL, USA).
Nuclear protein extraction
Cells were washed in PBS, harvested and resuspended in hypotonic buffer, and pelleted by centrifuging at 10 000 g for 10 min and supernatant discarded. Cells were lysed in hypotonic buffer containing 0.1% (v/v) Nonidet P-40, then centrifuged for 10 min at 10 000 g at 41C to pellet the nuclei. Nuclear pellets were resuspended in nuclear lysis buffer, incubated on ice for 30 min and centrifuged at 10 000 g at 41C for 10 min. The supernatant containing the nuclear extract was removed and added to 50 ml of storage buffer. Protein concentrations were determined using the BCA Protein Assay Reagent (Pierce).
Immunoblotting Protein (30 mg) was resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), then electroblotted onto Hybond membranes (Hybond-P, Amersham, Little Chalfont, UK). Antibody staining was performed with a chemiluminescence detection system (Supersignal, Pierce) using anti-IL-8 (Serotec, Oxford, UK), anti-HIF-1a or anti-HIF-1b (Novus Biologicals, Littleton, CO, USA) antibodies in conjunction with the appropriate horseradish peroxidase-conjugated secondary antibody (GE Healthcare UK Ltd, Buckinghamshire, UK). Equal protein loading was assessed using a GAPDH monoclonal primary antibody (Biogenesis, Poole, UK).
Immunoprecipitation
Total cellular lysate was extracted from PC3 cells in ELB lowsalt buffer (250 mM NaCl, 0.1% IGEPAL, 50 mM HEPES, 5 mM EDTA, 0.5 mM DTT, and protease inhibitor mixture (Boehinger Mannheim, Indianapolis, IN, USA)). Lysates were passed though a needle (21 gauge) and centrifuged, and protein concentration was determined using the BCA Protein Assay Reagent (Pierce). Protein A-sepharose beads were pre-associated with the anti-CXCR1 (Serotec) or anti-CXCR2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies for 18 h at 41C and then washed six times with ELB buffer. Precleared total protein (1 mg) was incubated with the antibody complex for 18 h, followed by six washes with ELB buffer. Immunoblotting was performed using the anti-CXCR1 (Santa Cruz Biotechnology) or anti-CXCR2 (Santa Cruz Biotechnology) antibodies.
ELISA Cells (5 Â 10 5 per well in a 24-well plate) were incubated in normoxic and hypoxic culture conditions for a range of timepoints up to 24 h. Medium was collected, centrifuged at 1000 g for 5 min and supernatant was stored at À801C until assayed. Cell number in each well was determined by parallel cell count analysis. IL-8 concentration in each sample was calculated by comparison to a standard curve generated from a stock vial of IL-8 calibrated against the World Health Organisation (WHO) interim international standard (1 WHO unit ¼ 10 ng IL-8). Assays were conducted according to the manufacturer's instructions (Pelikrine Compact IL-8 ELISA kit, Beckman Coulter, High Wycombe, UK). Absorbance readings were taken at 450 nM using a microwell plate reader (Molecular Devices).
Flow cytometry PC3 cells were resuspended in PBS containing 5% bovine serum albumin at a concentration of 1 Â 10 5 cells/ml. Cells were stained with fluorescein isothiocyanate (FITC)-conjugated monoclonal antibody against CXCR1 or CXCR2 (R&D Systems, Abingdon, UK) and analysed by flow cytometry (Beckman Coulter, Buckinghamshire, UK). Appropriate isotype controls were performed (FITC-conjugated mouse mAb IgG2a, R&D Systems).
EMSA Nuclear NF-kB was assessed by electrophoretic mobility shift assay using a 22-bp oligonucleotide previously end-labeled with [g-32 P]ATP. Following exposure to hypoxia, nuclear extracts were prepared and 4 mg of nuclear protein incubated with the radiolabeled oligonucleotide (35 000 c.p.m.) and resolved by PAGE as described previously (Boland et al., 1997) . Complexes were visualized by autoradiography of dried gels.
Real-time quantitative PCR Total RNA was isolated using RNAStat60 (Biogenesis, Oxford, UK) and 1 mg of total RNA was oligo(dT) reverse transcribed using MMLV-RT (Invitrogen), according to respective manufacturer's instructions. cDNA (50 ng) was mixed with primers (2 nM), sterile water and SYBR Green PCR mastermix (Finnzymes, Espoo, Finland 0 -CATAATTTCTGTTTGGCGCAGTGTGG-3 0 . Real-time PCR was carried out in a 96-well plate using an Opticon 2 Continuous Fluorescence Detector (Biorad, Hertfordshire, UK). The threshold cycle (C T ) value was calculated for each reaction by the Opticon 2 system. Unknown expression levels were determined from standard curve dilutions and normalized against 18 s.
Chromatin-IP assay PC3 cells (1 Â 10 6 ) were fixed in 1.5% formaldehyde for 15 min at 251C and cross-link stopped by washing in cold PBS. Cells were collected in cold collection buffer (100 mM Tris-HCl, pH 9.4, 10 mM DTT, protease inhibitor cocktail) and incubated on ice for 10 min. Cell/nuclei fragmentation was performed and lysates were sonicated to give DNA fragments of approximately 500 bp. An aliquot was removed for the 'input' sample and the remaining sample was precleared and subjected to immunoprecipitation with antibodies to HIF-1 (Abcam, Cambridge, UK), NF-kB (Abcam) and an IgG control antibody (HA, Santa Cruz Biotechnology). Following extraction of the specific protein/DNA complexes, the crosslink was reversed by heating to 651C for 16 h. The DNA was extracted using Quiquick columns (Qiagen, Crawley, UK) according to the manufacturer's instructions. The DNA was analysed for the presence of CXCR1 upstream region by PCR using the following primers CXCR1 5 0 -UTR: forward, 5 0 -TCAACCC CAGCTTCACACCT-3 0 , reverse, 5 0 -CCCCACCCATGTCTA CATTT-3 0 .
